Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving rats-Reference-Cited by-同舟云学术

Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving rats

Published:2020-03 Issue: Volume:22 Page:100554
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Janson Juliette,Andersson Gudrun,Bergquist Lars,Eriksson Maria,Folgering Joost H.A.

Funder

Swedish Orphan Biovitrum AB

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference19 articles.

1. Natural history of sanfilippo syndrome type a;Buhrman;J. Inherit. Metab. Dis.,2014

2. Antibody pharmacokinetics in rat brain determined using microdialysis;Chang;mAbs,2018

3. Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months;Chiu;Fluids Barriers CNS,2012

4. Assessment of α-synuclein secretion in mouse and human brain parenchyma;Emmanouilidou;PLoS One,2011

5. Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice;Gliddon;Pediatr. Res.,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier;Molecular Therapy;2023-03

2. Design and simulation of a neural interface based on a microfluidic flexible interconnection cable for chemical delivery;Micro and Nano Systems Letters;2022-11-19

3. Enhanced Thermal Stability of Polyphosphate-Dependent Glucomannokinase by Directed Evolution;Catalysts;2022-09-26

4. Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration;Frontiers in Pharmacology;2022-08-29

5. Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study;Molecular Genetics and Metabolism;2022-08